• STUDIES
    JOURNAL ARTICLE MEDICAL PERSPECTIVES MEDICAL PULSE STORIES
  • EVENTS
  • RESOURCES
    PPT ALL ARTICLE
  • ABOUT US
  • CONTACT US
  • LOGIN
  1. Home
  2. Posts
  3. Pharmacology behind Common Drug Nephrotoxicities

Pharmacology behind Common Drug Nephrotoxicities

Administrator 1 June, 2018
Acute Kidney Injury Drug Transporters Humans Nephrologists Nonprescription Drugs Pharmacology Proximal Tubulopathy Renal Elimination Risk acute renal failure drug nephrotoxicity kidney metabolism


Introduction:            

Drugs remain a relatively common cause of acute and chronic kidney injury, with the general population being exposed to a large number of prescribed and over-the-counter drugs. This also includes a variety of substances available at different health food stores. Drug-induced nephrotoxicity is more common in hospitalized patients, specifically among intensive care unit patients. A prospective cohort study of Acute Kidney Injury (AKI) cases revealed a 14 to 26 percent drug-induced nephrotoxicity in adults and 16 percent of hospitalized AKI in the pediatric population. Nephrotoxicity is also associated with different imaging agents used for diagnostic and therapeutic purposes.  

            In a study by Naughton, C. A., it has been shown that the average patient today is older, has more comorbidity, and is more exposed to diagnostic and therapeutic procedures that have potential risk for the kidney. It also mentioned that approximately 20 percent of community and hospital-acquired cases of acute renal injury is caused by drugs. Patients today, as mentioned in the article have higher incidences of diabetes and cardiovascular disease; hence ingestion of multiple medications and more exposure to procedures that are potentially harmful for the kidney.  

            Nephrotoxicity due to medications, drugs, and other ingested substances is a complicated process that involves a combination of factors, mainly drugs exerting toxic effects by one or more common pathogenic mechanisms. Other factors include the inherent nephrotoxic potential of the drug, underlying patient characteristics that enhance their risk for kidney injury, and the metabolism and excretion of the potential offending agent by the kidney.

 

Relevance:  

            Knowledge of the offending drugs and their pathogenic mechanisms of renal injury are crucial to recognizing and preventing drug-induced renal impairment. Development of kidney injury is initiated by exposure to a potentially toxic and offending agent. Most potentially nephrotoxic drugs are utilized in treating various disease processes. These include antimicrobial agents, anticancer drugs, analgesics, and immunosuppressive agents. In addition, new medications with still unknown nephrotoxic potential make it through clinical trials and are consequently utilized in clinical practice where they cause kidney injury.

 

Objectives:  

            The main goal of this study is to review and discuss the clinically relevant aspects of drug-induced nephrotoxicity for the clinical nephrologist and for clinical practice in general. It also aims to discuss different pathogenic mechanisms involved in drug-induced toxicity as well as their outcome with possible prevention and intervention.

 

Highlights:  

The Drug  

            The general population is exposed to a variety of potentially harmful (to the kidney) substances which includes prescribed therapeutic agents, over-the-counter products, diagnostic agents, and environmental substances. This is in part due to easy access to some of these medications. Exposure to a potentially toxic offending agent is known as an initial step in developing kidney injury. Alternative products which are made available at most health food stores include herbal remedies, natural products and nutritional supplements. The concern with these products is that some of them often contain a number of harmful chemicals and/or contaminants that are not listed in the label.  

            Drug dose and duration is another important cause of drug induced nephrotoxicity because of the innate kidney toxicity of the drug. High doses and prolonged courses of certain agents will enhance risk for kidney injury (via excessive exposure) even in patient with minimal or no underlying risk. Drugs that are insoluble in the urine may cause acute crystalline nephropathy, enhanced by reduced urinary flow rates, urine pH, excessive drug dosing, and rapid infusion rates. Other drugs are associated with osmotic nephropathy causing lysosomal dysfunction and cell swelling. Combination of nephrotoxic drugs increases risk for kidney injury and over-all drug toxicity. Other factors considered are drug-induced inflammation and cast nephropathy.

 

The Patient  

            Increased risk for medication-induced nephrotoxicity is related to a number of patient-specific factors. Some of which are nonmodifiable, such as older age and female sex due to their decreased lean body mass and reduced total body water that may lead to excess drug dosing. These patients have lower albumin concentration which leads to reduced drug binding and increased free drug concentration that can be nephrotoxic. Other patient factors that increase risk are the genetic makeup of immune response genes (heightened allergic response), drug metabolizing enzymes and transport pathways, comorbid conditions (liver disease, heart disease, and CKD), and acutely developed diseases (intravascular volume depletion, metabolic perturbations, and AKI).

 

The Kidney  

            An important contributing factor to drug nephrotoxicity that is also considered is the mechanism by which the kidney metabolizes and excretes various drugs and toxins. High rate blood delivery (~25% of cardiac output) to the kidneys exposes it to significant drug concentrations. Many tubular cells, specifically in the loop of Henle require high metabolic rates due to its hypoxic environment which also increases risk for kidney injury. Increased concentrations of certain medications in the medulla and interstitium induce kidney injuries through direct toxicity as well as ischemic damage from reduced prostaglandin and increased thromboxane production. Other kidney factors included are biotransformation of drugs to nephrotoxic metabolites and reactive oxygen species and proximal uptake of drugs (apical uptake, basolateral transport and reduced drug efflux).  

 

Conclusion:  

            Medications are extensively prescribed by clinicians and consumed by patients. This remains as common causes of kidney injury. Drug nephrotoxicity is a complicated process that involves a combination of factors. Knowledge of the offending drug and their pathogenic mechanisms of renal injury are critical in recognizing and preventing drug-induced renal impairment. It is also important to seek professional advice before taking any medication to prevent possible renal injury especially to those with comorbidities.

     

References:  

  • Perazella, M. Pharmacology behind Common Drug Nephrotoxicities. Clinical Journal of the American Society of Nephrology. 2018
  • https://www.aafp.org/afp/2008/...
  • https://patient.info/doctor/dr...

ABOUT PHAREX MEDICS

PharexMedICS is an online reference for medical students and doctors who would like to know more about trending medical issues, including clinical practice guidelines.

RELIABLE


Access medical information that are well-researched and sourced only from reputable medical society journals. We have a local expert panel/editorial board reviewing and aggregating information to ensure that only contents from credible sources will be part of the site.

UPDATED


Get the latest medical news and stay up to date with medical breakthroughs, trending issues and information in the medical field that are relevant to your practice.

RELEVANT


Take advantage of valuable information that are tailored for the Filipino doctors’ practice. Spend less time searching for information from multiple sources and have more time caring for your patients.

JOIN THE COMMUNITY

Access and share information, opinions, observations and more in our socials! These sites are specifically created for doctors and professionals in the field of medicine who want to expand their knowledge and learn more by interacting with your colleagues in the medical field. Participate in our health care discussions by signing up and becoming a member of our Group!

FACEBOOK
EMAIL

PRIVACY POLICY

 

Pharex treats the privacy of our customers with utmost respect and security. 

This Privacy Policy indicates the manner in which Pharex collects, uses, maintains and discloses information collected from the users of https://www.pharexmedics.com website (“Site”). 

This privacy policy applies to the Site and all products offered by Pharex. 

Read more.

 Pharex Medics. All Rights Reserved. 2017.

PHAREX MEDICS

By the doctors. For the doctors.

For the latest updates on events, services and products, please log in.

Register Here
Forgot Password?

OR


Privacy Policy

  • STUDIES
    • JOURNAL ARTICLE
    • MEDICAL PERSPECTIVES
    • MEDICAL PULSE
    • STORIES
  • EVENTS
    • RESOURCES
      • PPT
      • ALL ARTICLE
    • ABOUT US
      • CONTACT US
        • SEARCH
        • LOGIN

        We have an updated Privacy Statement

         

        Pharex Health Corporation respects your privacy and will keep secure and confidential all personal and sensitive information that you may provide to Pharex Health Corporation and/or those that Pharex Health Corporation may collect from you ("Personal Data")

        Please read carefully the Pharex Health Corporation Privacy Statement to understand how we treat Personal Data.

        Click here to read the Privacy Statement in full.


        Pharex Health Corporation uses cookies to customize user experience. By continued use, you agree to our privacy policy and accept our use of such cookies. For full details, click to read our privacy policy.